Found 7 matching trials
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
PHASE1ASpiRE will investigate the effect of the drug SX-682 in combination with A...
Location
Oncology Institute of Southern Switzerland
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)
PHASE2ARES is a multicenter, single-arm, phase 2 trial to evaluate the efficacy a...
Location
Nanjing First Hospital, Nanjing Medical University
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
PHASE2This is a phase II randomized, open-label study comparing salvage radiother...
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
PHASE2This study is open to men who have biochemical recurrence (BCR, increased P...
Location
UTHealth Memorial Hermann Cancer Center
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
PHASE2The objective of this study is to see if providing an appropriate therapy b...
Location
University of California Davis
Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
PHASE2The primary objective of this trial is to determine if adjuvant apalutamide...
Status
Active Not Recruiting
Location
Medizinische Universität Innsbruck
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
PHASE2This phase II trial studies the how well apalutamide with or without stereo...
Location
University of California, San Francisco